Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Phase I/II Safety and Preliminary Efficacy of PM1022, a Bispecific Antibody Targeting PD-L1 and TIGIT, in Patients with Advanced Solid Tumors.

Junli Xue,Yan Zhang,Xudong Hu, Wei Zhao,Yuping Sun,Qun Li, Xiaoying Jin,Liqiong Xue,Xiaoxiao Ge,Fengjuan Lin,Wenbo Tang,Jiuli Zhou,Ye Guo

JOURNAL OF CLINICAL ONCOLOGY（2024）

Cited 0|Views22
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined